New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.
about
Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathyStructural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate.Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain TransitionAdenylyl cyclase type 5 in cardiac disease, metabolism, and aging.Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes.Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.Oscillation of cAMP and Ca(2+) in cardiac myocytes: a systems biology approach.North American ginseng (Panax quinquefolius) suppresses β-adrenergic-dependent signalling, hypertrophy, and cardiac dysfunction.Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects.Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation.
P2860
Q34357713-1F52A992-43E4-4B4A-930B-48485B11FA14Q35080520-7DF9A96D-377F-4922-8382-C297419C73D9Q35656679-D26C65E6-40A2-45B8-BB6B-A4AC36045410Q37054928-41465BC0-6B71-4E27-932A-EED6DB9276D3Q42486657-CA8B178B-D1D6-4BE2-9B27-FEF9F47A9C23Q42751004-9F810A7F-BBBA-49FF-BFDD-806C97F47B2BQ50977219-F1543815-881E-4001-9825-B69611E6782FQ51353970-BBC9AB12-CBEB-4E58-8B12-16D8298A523CQ51568037-F1EF68BD-7C29-438C-9D92-E9FD957EAE6FQ52654611-C9F76E7C-36DB-4A32-B870-AC42D25170B5
P2860
New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@nl
type
label
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@nl
prefLabel
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@nl
P2093
P356
P1476
New aspects for the treatment ...... type 5 adenylyl cyclase gene.
@en
P2093
Satoshi Okumura
Sayaka Suzuki
Yoshihiro Ishikawa
P304
P356
10.1254/JPHS.08R26FM
P577
2009-03-07T00:00:00Z